ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: FR-PO959

Hematopoietic Cell Kinase (HCK) Is a Key Regulator of Macrophage Function in Kidney Fibrosis

Session Information

  • CKD: Pathobiology - I
    November 04, 2022 | Location: Exhibit Hall, Orange County Convention Center‚ West Building
    Abstract Time: 10:00 AM - 12:00 PM

Category: CKD (Non-Dialysis)

  • 2203 CKD (Non-Dialysis): Mechanisms

Authors

  • Wei, Chengguo, Icahn School of Medicine at Mount Sinai Department of Medicine, New York, New York, United States
  • Chen, Man, Icahn School of Medicine at Mount Sinai Department of Medicine, New York, New York, United States
  • Zhang, Weijia, Icahn School of Medicine at Mount Sinai Department of Medicine, New York, New York, United States
  • Lee, Kyung, Icahn School of Medicine at Mount Sinai Department of Medicine, New York, New York, United States
  • He, John Cijiang, Icahn School of Medicine at Mount Sinai Department of Medicine, New York, New York, United States
Background

Our previous study identified HCK as a regulator of renal fibrosis. We recently find HCK could regulate autophagy in macrophages. Here we tested HCK's role in macrophage function in the context of renal fibrosis.

Methods

Bone marrow-derived macrophage (BMDM) and RAW264.7 macrophage in vitro and UUO in vivo for global, macrophage HCK-KO and WT mice were used to determine the effects of HCK on macrophage autophagy and activation.

Results

Single cell sequencing data confirmed that HCK is mainly expressed in macrophages (Fig. 1A). IP/MS identified HCK interacts with autophagy proteins ATG2A and CBL(data not shown) and confirmed by IP/WB (Fig. 1B) in macrophage cell line RAW264.7. KO of HCK increased autophagy activity as increased LC3II/LC3I ratio and decreased P62 in BMDM (Fig. 1C). We also found KO of HCK decreased macrophage M1 polarization and increased M2 polarization in BMDM by qPCR, WB(Fig. 1D, 1E), and flow cytometry (Fig. 1F). In the UUO model, we found that global and macrophage-specific HCK-KO mice had significantly attenuated tubulointerstitial fibrosis with decreased mRNA profibrotic markers (Fig. 2C) and Masson’s trichrome staining (Fig. 2D, 2E).

Conclusion

HCK promotes kidney fibrosis by suppressing macrophage autophagy and inducing macrophage polarization.